Olympus had two patents in robotics during Q2 2024. Olympus Corp has developed systems, devices, and methods for planning endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA) from an anatomical target. This includes using an endoscopy system with a steerable elongate instrument, EUS probe, tissue acquisition device, and a processor that applies images to a machine-learning model to generate an EUS-TA plan. The plan includes recommendations for the tissue acquisition device and operational parameters, which can be presented to a user or used for robot-assisted tissue acquisition procedures. GlobalData’s report on Olympus gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Olympus Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Olympus had no grants in robotics as a theme in Q2 2024.

Recent Patents

Application: Endoscopic ultrasound guided tissue acquisition (Patent ID: US20240197403A1)

The patent filed by Olympus Corp. describes systems, devices, and methods for planning endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA) from an anatomical target. The endoscopy system includes a steerable elongate instrument with an EUS probe for ultrasound scans and a tissue acquisition device for sampling tissue. A processor uses machine-learning models to generate an EUS-TA plan based on received images of the anatomical target, recommending operational parameters for tissue acquisition device manipulation, instrument navigation, or probe positioning. The EUS-TA plan can be presented to a user or used for robot-assisted tissue acquisition procedures.

The patent includes claims detailing the components and functionalities of the endoscopic system, such as the use of preoperative or perioperative images, selection of image subsets based on quality, and the incorporation of a force sensor to maintain contact force during ultrasound scans. The system also involves a user interface for presenting images and plans, a controller for robotic assistance, and a training module for machine-learning model development. The EUS-TA plan can recommend specific tissue acquisition devices, ablation devices, or operational parameters for instrument navigation and probe positioning. Additionally, the system can recognize lesions, determine tissue malignancy, and provide real-time microscopic imaging for further analysis and user visualization.

To know more about GlobalData’s detailed insights on Olympus, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.